TickerFactsScreenerDevelopers

REVELATION BIOSCIENCES, INC. (REVB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$216.7K2021: -$11.09M2022: -$11.22M2023: -$7.29M2024: -$18.32M2025: -$8.27M-$8.27M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$8.27M+54.9%
2024-$18.32M-151.4%
2023-$7.29M+35.1%
2022-$11.22M-1.2%
2021-$11.09M-5018.8%
2020-$216.7K—